MEDNAX, Inc. Forecast, price target & analysts
MEDNAX, Inc. Target price 2025 - Analyst rating & recommendation
MEDNAX, Inc. Classifications & Recommendation:
MEDNAX, Inc. Price Target
| Target Price | $17.14 |
| Price | $15.16 |
| Potential |
13.08%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target MEDNAX, Inc. 2026 .
The average MEDNAX, Inc. target price is $17.14.
This is
13.08%
register free of charge
$21.00
38.52%
register free of charge
$14.00
7.65%
register free of charge
|
|
| A rating was issued by 8 analysts: 3 Analysts recommend MEDNAX, Inc. to buy, 5 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the MEDNAX, Inc. stock has an average upside potential 2026 of
13.08%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 2.01 | 1.87 |
| 0.92% | 6.91% | |
| EBITDA Margin | 10.73% | 12.55% |
| 10.27% | 17.00% | |
| Net Margin | -5.07% | 6.56% |
| 61.53% | 229.31% |
8 Analysts have issued a sales forecast MEDNAX, Inc. 2025 . The average MEDNAX, Inc. sales estimate is
This results in the following potential growth metrics:
8 Analysts have issued an MEDNAX, Inc. EBITDA forecast 2025. The average MEDNAX, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 MEDNAX, Inc. Analysts have issued a net profit forecast 2025. The average MEDNAX, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.19 | 1.43 |
| 63.01% | 220.17% | |
| P/E | 10.58 | |
| EV/Sales | 0.93 |
5 Analysts have issued a MEDNAX, Inc. forecast for earnings per share. The average MEDNAX, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Current MEDNAX, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| UBS |
Locked
➜
Locked
|
Locked | May 12 2025 |
| Macquarie |
Locked
➜
Locked
|
Locked | May 08 2025 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Apr 11 2025 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Feb 21 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Feb 21 2025 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Jan 06 2025 |
| Macquarie |
Locked
➜
Locked
|
Locked | Dec 16 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
UBS:
Locked
➜
Locked
|
May 12 2025 |
|
Locked
Macquarie:
Locked
➜
Locked
|
May 08 2025 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Apr 11 2025 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Feb 21 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Feb 21 2025 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Jan 06 2025 |
|
Locked
Macquarie:
Locked
➜
Locked
|
Dec 16 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
